Literature

News Digest for February 2019


February 1, 2019

Rhein shows potent efficacy against non-small-cell lung cancer through inhibiting the STAT3 pathway (here)

Tumors with…

Read More

News Digest for January 2019


January 2, 2019

Spectrum Pharmaceuticals Announces Full Enrollment of the Poziotinib EGFR Cohort for Previously Treated Non-Small Cell Lung Cancer…

Read More

Innovent Biologics has revealed that China’s National Medical Products Administration has approved its application to test a combination therapy comprising a proposed biosimilar bevacizumab product, IBI305, plus sintilimab


China-based drug maker Innovent Biologics has revealed that China’s National Medical Products Administration has approved its application to test a…

Read More

Innovent Biologics has revealed that China’s National Medical Products Administration has approved its application to test a combination therapy comprising a proposed biosimilar bevacizumab product, IBI305, plus sintilimab


China-based drug maker Innovent Biologics has revealed that China’s National Medical Products Administration has approved its application to test a…

Read More

FAM129B promoted tumor invasion and proliferation via facilitating the phosphorylation of FAK signaling and associated with adverse clinical outcome of non-small cell lung cancer patients


FAM129B promoted tumor invasion and proliferation via facilitating the phosphorylation of FAK signaling and associated with adverse clinical outcome of…

Read More

Management strategies for NSCLC patients who experienced hyperprogressive disease during the first cycle of nivolumab


A retrospective case series analysis, published in Thoracic Cancer, described management strategies for non-small cell lung cancer (NSCLC) patients who…

Read More